X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (299) 299
Publication (27) 27
Conference Proceeding (3) 3
Book / eBook (1) 1
Book Chapter (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (140) 140
male (101) 101
middle aged (98) 98
female (96) 96
adult (91) 91
aged (84) 84
oncology (81) 81
antineoplastic combined chemotherapy protocols - therapeutic use (77) 77
hematology (63) 63
index medicus (60) 60
treatment outcome (52) 52
chemotherapy (47) 47
prognosis (44) 44
rituximab (42) 42
lymphomas (40) 40
neoplasm staging (39) 39
aged, 80 and over (34) 34
non-hodgkins-lymphoma (34) 34
combined modality therapy (33) 33
antineoplastic combined chemotherapy protocols - adverse effects (32) 32
recurrence (31) 31
hodgkin disease - drug therapy (30) 30
vincristine - administration & dosage (27) 27
cancer (26) 26
disease-free survival (26) 26
follow-up studies (26) 26
lymphoma (26) 26
adolescent (25) 25
lymphoma, non-hodgkin - drug therapy (25) 25
therapy (25) 25
retrospective studies (24) 24
survival rate (24) 24
remission induction (23) 23
article (22) 22
care and treatment (22) 22
hodgkin's disease (21) 21
radiotherapy (21) 21
cyclophosphamide - administration & dosage (20) 20
prednisone - administration & dosage (20) 20
young adult (20) 20
antineoplastic combined chemotherapy protocols - administration & dosage (19) 19
doxorubicin - administration & dosage (18) 18
survival (18) 18
survival analysis (18) 18
drug administration schedule (17) 17
cyclophosphamide (16) 16
hodgkin disease - radiotherapy (16) 16
dexamethasone - administration & dosage (15) 15
disease (15) 15
follicular lymphoma (15) 15
hodgkin disease - pathology (15) 15
non-hodgkin's lymphomas (15) 15
research (15) 15
transplantation (15) 15
chronic lymphocytic-leukemia (14) 14
lymphoma, follicular - drug therapy (14) 14
lymphoma, large b-cell, diffuse - drug therapy (14) 14
mitoxantrone - administration & dosage (14) 14
antibodies, monoclonal, murine-derived (13) 13
antibodies, monoclonal, murine-derived - administration & dosage (13) 13
b-cell lymphoma (13) 13
lymphoma - drug therapy (13) 13
time factors (13) 13
analysis (12) 12
hematology, oncology and palliative medicine (12) 12
hematopoietic stem cell transplantation (12) 12
non-hodgkin lymphoma (12) 12
prognostic factors (12) 12
antibodies, monoclonal - administration & dosage (11) 11
antineoplastic agents - therapeutic use (11) 11
cyclophosphamide - adverse effects (11) 11
cytarabine - administration & dosage (11) 11
doxorubicin - adverse effects (11) 11
doxorubicin - therapeutic use (11) 11
expression (11) 11
prednisone (11) 11
risk factors (11) 11
trial (11) 11
vincristine (11) 11
vincristine - adverse effects (11) 11
vincristine - therapeutic use (11) 11
classification (10) 10
fludarabine (10) 10
hodgkin disease - therapy (10) 10
leukemia (10) 10
lymphoma, follicular - mortality (10) 10
lymphoma, non-hodgkin - pathology (10) 10
methotrexate - administration & dosage (10) 10
patient outcomes (10) 10
prednisone - therapeutic use (10) 10
vidarabine - administration & dosage (10) 10
vidarabine - analogs & derivatives (10) 10
vinblastine - administration & dosage (10) 10
chop (9) 9
drug therapy (9) 9
hodgkin disease - mortality (9) 9
lymphoma, large b-cell, diffuse - mortality (9) 9
lymphoma, large b-cell, diffuse - pathology (9) 9
non‐hodgkin lymphoma (9) 9
phase-ii (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 1, pp. 69 - 77
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. 1311 - 1318
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 716 - 723
Journal Article
[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 01/2016, Volume 57, Issue 10, pp. 2049 - 2053
Many patients with Hodgkin lymphoma (HL) can be cured with standard chemotherapy with high long term survival rates . Considering the increased risks of... 
Hodgkin Disease - therapy | Humans | Immunotherapy | Immunoconjugates - therapeutic use | Hodgkin Disease - immunology | Ki-1 Antigen - immunology | T-Lymphocytes - immunology | Programmed Cell Death 1 Receptor - immunology
Journal Article
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, ISSN 1073-449X, 06/2019, Volume 199, Issue 12, pp. E43 - E44
(B and C) Pleural biopsy reveals a thin zone of mixed inflammatory cells beneath the pleura (B, hematoxylin and eosin stain) and at higher magnification (C,... 
RESPIRATORY SYSTEM | THERAPY | CRITICAL CARE MEDICINE | Edema | Cardiac arrhythmia | Ultrasonic imaging | Dyspnea | Leukemia | Lymphomas | Catheters
Journal Article
Drugs, ISSN 0012-6667, 02/2010, Volume 70, Issue 3, pp. 261 - 272
Rituximab is a monoclonal antibody that is widely utilized in the treatment of a number of B-cell-derived haematological malignancies. Rituximab, in... 
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2018, Volume 13, Issue 3, p. e0191461
Journal Article
BioDrugs, ISSN 1173-8804, 11/2012, Volume 26, Issue 6, p. 363
Observation until the development of symptoms, or 'watch and wait', has long been a proposed management technique for patients with indolent lymphomas.... 
Reports | Care and treatment | Lymphomas | Forecasts and trends | Watchful waiting (Medical care)
Journal Article
BioDrugs, ISSN 1173-8804, 12/2012, Volume 26, Issue 6, pp. 363 - 376
Observation until the development of symptoms, or 'watch and wait', has long been a proposed management technique for patients with indolent lymphomas.... 
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 1, pp. 175 - 182
Purpose Few studies to date have evaluated factors associated with the development of radiation pneumonitis (RP) in patients with Hodgkin lymphoma (HL) and... 
Radiology | Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | VOLUME HISTOGRAM ANALYSIS | IRRADIATION | PULMONARY TOXICITY | ONCOLOGY | DISEASE | INSPIRATION BREATH-HOLD | HIGH-DOSE CHEMOTHERAPY | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | TRANSPLANTATION | Doxorubicin - therapeutic use | Salvage Therapy - adverse effects | Radiation Pneumonitis - etiology | Dacarbazine - therapeutic use | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Male | Vinblastine - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Young Adult | Hodgkin Disease - radiotherapy | Mediastinal Neoplasms - drug therapy | Bleomycin - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Lung - radiation effects | Retrospective Studies | Lymphoma, Non-Hodgkin - drug therapy | Radiotherapy Dosage | Regression Analysis | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - radiotherapy | Adolescent | Salvage Therapy - methods | Care and treatment | Pneumonia | Chemotherapy | Bacterial pneumonia | Stem cells | Radiation | Lymphomas | Radiotherapy | Cancer | Index Medicus | REVIEWS | DIAGNOSIS | PATIENTS | LUNGS | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | LYMPHOMAS | MULTIVARIATE ANALYSIS | MEDIASTINUM | RADIOLOGY AND NUCLEAR MEDICINE | PNEUMONITIS | STEM CELLS | HAZARDS
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2017, Volume 176, Issue 5, pp. 750 - 758
Journal Article